Last reviewed · How we verify
NCT07213180: RETROUVE
Study of the Return to Driving in People Who Have Suffered a Cerebrovascular Accident (CVA)
trial in Post-stroke in 140 participants. Completed in 25 September 2023.
25 March 2023
Quick facts
| Lead sponsor | Centre Mutualiste de Rééducation et de Réadaptation Fonctionnelles de Kerpape |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 140 |
| Start date | 25 November 2022 |
| Primary completion | 25 March 2023 |
| Estimated completion | 25 September 2023 |
| Sites | 1 location across France |
Conditions studied
- Post-stroke — all drugs for Post-stroke →
Sponsor
Centre Mutualiste de Rééducation et de Réadaptation Fonctionnelles de Kerpape
Who can join
Adults 18 to 85, any sex, with Post-stroke. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The RETROUVE study will provide healthcare professionals, patients and their families informations on the rate of return to driving in people who have suffered a stroke, and will provide a better understanding of the various factors that explain this return. This bi-centric study is being conducted in 2 parts: a retrospective part involving an analysis of medical records, and a prospective part involving a telephone questionnaire. The main aim of this study is to assess the rate of return to driving in patients who have suffered a stroke, following an assessment of their fitness to drive. It will also aim to study the factors that explain a return to driving in post-stroke patients.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07213180
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Post-stroke
Currently open trials in the same condition.
- NCT07078175 — Xingnao Kaiqiao Acupuncture vs Electroacupuncture for Post-Stroke Upper Limb Recovery · NA · recruiting
- NCT03930121 — Transcranial Direct Current Stimulation to Enhance Training Effectiveness in Chronic Post-Stroke Aphasia · NA · active not recruiting
Other Centre Mutualiste de Rééducation et de Réadaptation Fonctionnelles de Kerpape trials
Trials by the same sponsor.
- NCT07419087 — Trunk Impairment Scale - Adaptation and Validation in French · NA · not yet recruiting
- NCT06524128 — Evaluation of Perceived Satisfaction With the Use of the Dreeft® Device in Real-life Situations · NA · completed
- NCT07212257 — Creation of a Pediatric Reference Database for the Kerpape-Rennes-EMG-Based Gait Index · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07213180 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Centre Mutualiste de Rééducation et de Réadaptation Fonctionnelles de Kerpape
- Last refreshed: 8 October 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07213180.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing